Oracle Health Sciences has released Oracle Health Sciences ClearTrial Plan and Source Enterprise Edition Cloud Service 5.0, the latest version of the cloud-based clinical trial operations solution that enables life sciences organizations to plan, source and track clinical projects and financial performance via a single, integrated platform.

The newest release now provides support for phase I trials, which when combined with existing capabilities, enables organizations to support a broad range of clinical trials—from initial safety screenings to complex testing and post-approval studies—in one scalable and flexible solution.

Further expanding the breadth and study types that sponsors and CROs can create and track, the latest release also provides support for multiple treatment arm studies—including complex cross-over studies, in which different types and sequences of treatment courses are administered to various study groups.

“We remain committed to evolving the breadth and depth of Oracle ClearTrial Plan and Source Cloud Service’s capabilities to provide life sciences organizations with the tools they need to conduct and track increasingly complex clinical trials across diverse geographies, outsourcers, therapeutic areas and trial phases,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences. “The new capabilities will allow life sciences organizations to gain a competitive edge in the marketplace while accelerating the process of bringing new therapies to market.”

Oracle Health Sciences ClearTrial Plan and Source is now delivered via the Oracle Health Sciences Cloud, providing users with improved performance, availability and fault tolerance. In addition, as a cloud-based solution, users will gain immediate access to ClearTrial’s enhanced functionality and improved user interface.